Glucagon-like peptide 1 (7-36) amide (human, rat)

Glucagon-like peptide 1 (7-36) amide (human, rat) is a synthetic peptide fragment that corresponds to the biologically active region of endogenous GLP-1, a key incretin hormone involved in metabolic regulation. This peptide is widely recognized for its ability to stimulate insulin secretion in a glucose-dependent manner and inhibit glucagon release, thereby modulating glucose homeostasis. Structurally, GLP-1 (7-36) amide is characterized by its amide modification at the C-terminus, which enhances its biological stability and mimics the natural form found in both humans and rats. Its high degree of conservation across species makes it an invaluable research tool for comparative physiological and pharmacological studies. The peptide's interaction with the GLP-1 receptor, a member of the class B G protein-coupled receptor family, triggers a cascade of intracellular signaling events that are essential for understanding the molecular basis of metabolic diseases. Researchers value this compound for its specificity, well-characterized mode of action, and its relevance to both basic and translational research in endocrinology and metabolism.

Metabolic Disease Modeling: Glucagon-like peptide 1 (7-36) amide is extensively utilized in preclinical models to investigate the pathophysiology of metabolic disorders, such as type 2 diabetes and obesity. By administering this peptide to animal models, scientists can study its effects on insulin secretion, glucose uptake, and overall energy balance. These experiments help elucidate the mechanisms by which GLP-1 modulates pancreatic beta cell function and peripheral glucose utilization. The ability to replicate the physiological actions of endogenous GLP-1 in both human and rat systems enables researchers to bridge findings across species, facilitating the development of novel therapeutic strategies and the identification of new drug targets.

Receptor Signaling Research: GLP-1 (7-36) amide serves as a powerful tool for dissecting the signaling pathways associated with the GLP-1 receptor. In cell-based assays, it is commonly used to stimulate receptor activation, allowing scientists to monitor downstream effects such as cyclic AMP production, protein kinase A activation, and changes in gene expression. These studies provide critical insights into the molecular interactions and regulatory mechanisms that govern incretin signaling. Furthermore, the peptide's specificity for the GLP-1 receptor makes it ideal for differentiating between receptor-mediated and non-receptor-mediated effects, thereby enhancing the accuracy and interpretability of experimental results.

Appetite and Satiety Regulation: The role of GLP-1 (7-36) amide in appetite control and satiety has garnered significant attention in neuroscience and behavioral research. When administered centrally or peripherally, the peptide has been shown to reduce food intake and influence feeding behavior in animal models. By investigating these effects, researchers aim to unravel the neural circuits and hormonal pathways involved in energy intake regulation. Such studies contribute to a deeper understanding of obesity and related disorders, offering potential avenues for the development of appetite-modulating interventions.

Beta Cell Function and Survival: The peptide is also instrumental in studies focused on pancreatic beta cell health, proliferation, and apoptosis. Through in vitro and in vivo experiments, scientists use GLP-1 (7-36) amide to assess its protective and regenerative effects on beta cells exposed to metabolic or oxidative stress. These investigations are crucial for identifying factors that promote beta cell survival and for developing strategies to preserve or restore endogenous insulin production in diabetes research. The peptide's ability to mimic physiological incretin effects makes it a preferred choice for these applications.

Cardiovascular and Renal Physiology: Beyond metabolic regulation, GLP-1 (7-36) amide is increasingly employed in studies exploring its impact on cardiovascular and renal systems. Research has demonstrated that the peptide can modulate heart rate, blood pressure, and renal function through direct and indirect mechanisms. By leveraging its receptor-mediated actions, scientists are able to investigate the interplay between metabolic and cardiovascular health, as well as the potential protective effects of incretin signaling on organ function. These multifaceted applications underscore the scientific value of GLP-1 (7-36) amide in advancing our understanding of complex physiological processes and their relevance to human health.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. High fat diet and GLP-1 drugs induce pancreatic injury in mice

3. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

4. Emu oil in combination with other active ingredients for treating skin imperfections

5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum